Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

Videos | Left Atrial Appendage (LAA) Occluders | October 01, 2018
VIDEO: Comparison Between Watchman vs. Amulet LAA Occluders
Ashish Pershad, M.D., medical director, structural heart program, Banner University Medical Heart Institute, Phoenix,...
read more
Antithrombin Drug Ineffective in Heart Failure With Sinus Rhythm and Coronary Disease
News | Heart Failure | September 07, 2018
Antithrombin Drug Ineffective in Heart Failure With Sinus Rhythm and Coronary Disease
September 7, 2018 — The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival,...
read more
Thrombolytic Science Initiates Phase 2 Trial of Novel Ischemic Stroke Treatment Regimen
News | Antiplatelet and Anticoagulation Therapies | September 07, 2018
Thrombolytic Science Initiates Phase 2 Trial of Novel Ischemic Stroke Treatment Regimen
September 7, 2018 — A new Phase 2 clinical trial looks to confirm the efficacy and safety of Thrombolytic Science LLC’s...
read more
Tafamidis Improves Survival in Rare Heart Condition
News | Heart Failure | September 06, 2018
Tafamidis Improves Survival in Rare Heart Condition
September 6, 2018 — Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart...
read more
Bleeds and Benefit With Aspirin Balanced in Diabetes Patients
News | Antiplatelet and Anticoagulation Therapies | September 05, 2018
Bleeds and Benefit With Aspirin Balanced in Diabetes Patients
September 5, 2018 — Aspirin prevented serious vascular events in patients with diabetes who did not already have...
read more
Effect of Daily Aspirin on First-Time Heart Attack and Stroke Risk Inconclusive
News | Pharmaceuticals | September 04, 2018
Effect of Daily Aspirin on First-Time Heart Attack and Stroke Risk Inconclusive
September 4, 2018 — The jury is still out on whether people at moderate risk of a first heart attack or stroke should...
read more
Extended Post-Hospital Oral Anticoagulant Use Reduces Non-Fatal Blood Clots
News | Antiplatelet and Anticoagulation Therapies | August 31, 2018
Extended Post-Hospital Oral Anticoagulant Use Reduces Non-Fatal Blood Clots
August 31, 2018 — Use of an oral anticoagulant in medically ill patients for 45 days following hospital discharge...
read more
Blood Pressure and Cholesterol-lowering Drugs Continue to Improve Survival After a Decade
News | Pharmaceuticals | August 27, 2018
Blood Pressure and Cholesterol-lowering Drugs Continue to Improve Survival After a Decade
August 27, 2018 — Blood pressure and cholesterol-lowering drugs continue to improve survival in patients with...
read more
Xarelto Associated With Reduced Hospital Time and Costs for Low-risk PE Patients
News | Pulmonary Embolism | June 29, 2018
Xarelto Associated With Reduced Hospital Time and Costs for Low-risk PE Patients
June 29, 2018 — Results from the MERCURY PE study showed that low-risk pulmonary embolism (PE) patients treated with...
read more
AFib Patients Want More Information About Anticoagulation Reversal
News | Antiplatelet and Anticoagulation Therapies | June 27, 2018
AFib Patients Want More Information About Anticoagulation Reversal
June 27, 2018 — Results from a 902-person, five-country survey of people living with atrial fibrillation (AF) reinforce...
read more
Medisafe Demonstrates Double-Digit Impact on Hypertension Medication Adherence
News | Mobile Devices | June 13, 2018
Medisafe Demonstrates Double-Digit Impact on Hypertension Medication Adherence
June 13, 2018 — Medication management platform Medisafe released data showing that, on average, hypertensive patients...
read more
International Study Suggests Combination Therapy May Prevent Stroke in Certain People
News | Stroke | June 07, 2018
International Study Suggests Combination Therapy May Prevent Stroke in Certain People
June 7, 2018 — Results from an international clinical trial show that combining clopidogrel and aspirin following a...
read more
Gencaro Does Not Reduce Atrial Fibrillation Risk in Heart Failure Patients
News | Heart Failure | May 30, 2018
Gencaro Does Not Reduce Atrial Fibrillation Risk in Heart Failure Patients
May 30, 2018 — Data from the GENETIC-AF trial was presented in a “Late Breaking Clinical Trials” oral presentation at...
read more
OCT Reveals Excellent Healing Profile for Complex CAD Patients With Resolute Onyx DES
News | Stents Drug Eluting | May 29, 2018
OCT Reveals Excellent Healing Profile for Complex CAD Patients With Resolute Onyx DES
May 29, 2018 – Investigators recently unveiled clinical data from the independently run Onyx 1-Month OCT Study showing...
read more
A slide image from Reddy's presntation at Heart Rhythm 2018, showing thrombus formation on the face of a Watchman LAA Occluder device in an echo image. #HRS2018

A slide image from Reddy's presntation at Heart Rhythm 2018, showing thrombus formation on the face of a Watchman device in an echo image.

Feature | Left Atrial Appendage (LAA) Occluders | May 18, 2018
Device-related Thrombus After Watchman LAA Closure Occurs in Small Number of Patients
May 18, 2018 — Left atrial appendage closure (LAAC) with the transcatheter Watchman device prevents thromboembolism...
read more
© Copyright Wainscot Media. All Rights Reserved.